Free Access
Issue
Méd. Intensive Réa.
Volume 26, Number 3, Mai 2017
Infectieux
Page(s) 177 - 187
Section Mise au point / Update
DOI https://doi.org/10.1007/s13546-017-1268-x
Published online 06 April 2017
  • Zumla A, Raviglione M, Hafner R, von Reyn CF, (2013) Tuberculosis. N Engl J Med 368: 745–755 [CrossRef] [PubMed] [Google Scholar]
  • The Centers for Disease Control and Prevention tNIoH, the HIV Medicine Association of the Infectious Diseases Society of America Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents (available at www.aidsinfo.nih.gov, last access on December 30, 2016) [Google Scholar]
  • Aït Belhiti F, Antoine D, (2015) L'épidémiologie de la tuberculose en France en 2013. Bull Epidemiol Hebd 9–10: 164–171 [Google Scholar]
  • World Heatlh Organization Global tuberculous report 2015 (available at www.who.int) [Google Scholar]
  • Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR, (2012) Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis 54: 784–791 [CrossRef] [PubMed] [Google Scholar]
  • Dheda K, Barry CE3rd, Maartens G, (2016) Tuberculosis. Lancet 387: 1211–1226 [CrossRef] [PubMed] [Google Scholar]
  • Zahar JR, Azoulay E, Klement E, De Lassence A, Lucet JC, Regnier B, Schlemmer B, Bedos JP, (2001) Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 27: 513–520 [CrossRef] [PubMed] [Google Scholar]
  • Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, Lode H, (2006) Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J 27: 1223–1228 [PubMed] [Google Scholar]
  • Lanoix JP, Gaudry S, Flicoteaux R, Ruimy R, Wolff M, (2014) Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country. Int J Tuberc Lung Dis 18: 581–587 [CrossRef] [PubMed] [Google Scholar]
  • Valade S, Raskine L, Aout M, Malissin I, Brun P, Deye N, Baud FJ, Megarbane B, (2012) Tuberculosis in the intensive care unit: a retrospective descriptive cohort study with determination of a predictive fatality score. Can J Infect Dis Med Microbiol 23: 173–178 [PubMed] [Google Scholar]
  • Silva DR, Menegotto DM, Schulz LF, Gazzana MB, Dalcin PT, (2010) Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study. BMC Infect Dis 10: 54 [CrossRef] [PubMed] [Google Scholar]
  • Loh WJ, Yu Y, Loo CM, Low SY, (2016) Factors associated with mortality among patients with active pulmonary tuberculosis requiring intensive care. Singapore Med J [in press] [Google Scholar]
  • Balkema CA, Irusen EM, Taljaard JJ, Koegelenberg CF, (2014) Tuberculosis in the intensive care unit: a prospective observational study. Int J Tuberc Lung Dis 18: 824–830 [PubMed] [Google Scholar]
  • Lin SM, Wang TY, Liu WT, Chang CC, Lin HC, Liu CY, Wang CH, Huang CD, Lee KY, Kuo HP, (2009) Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure. Int J Tuberc Lung Dis 13: 335–340 [PubMed] [Google Scholar]
  • Deng W, Yu M, Ma H, Hu LA, Chen G, Wang Y, Deng J, Li C, Tong J, Wang DX, (2012) Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China. BMC Infect Dis 12: 121 [CrossRef] [PubMed] [Google Scholar]
  • Yang JY, Han M, Koh Y, Kim WS, Song JW, Oh YM, Lee SD, Lee SW, Lee JS, Lim CM, Choi CM, Huh JW, Hong SB, Shim TS, Jo KW, (2016) Effects of corticosteroids on critically ill pulmonary tuberculosis patients with acute respiratory failure: a propensity analysis of mortality. Clin Infect Dis 63: 1449–1455 [CrossRef] [PubMed] [Google Scholar]
  • Bhurayanontachai R, Maneenil K, (2016) Factors influencing development and mortality of acute respiratory failure in hospitalized patient with active pulmonary tuberculosis: a 10-year retrospective review. J Thorac Dis 8: 1721–1730 [CrossRef] [PubMed] [Google Scholar]
  • Levy H, Kallenbach JM, Feldman C, Thorburn JR, Abramowitz JA, (1987) Acute respiratory failure in active tuberculosis. Crit Care Med 15: 221–225 [CrossRef] [PubMed] [Google Scholar]
  • Hashemian SM, Tabarsi P, Karam MB, Kahkouee S, Marjani M, Jamaati H, Shekarchi N, Mohajerani SA, Velayati AA, (2015) Radiologic manifestations of pulmonary tuberculosis in patients of intensive care units. Int J Mycobacteriol 4: 233–238 [Google Scholar]
  • Maartens G, Willcox PA, Benatar SR, (1990) Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 89: 291–296 [CrossRef] [PubMed] [Google Scholar]
  • Piqueras AR, Marruecos L, Artigas A, Rodriguez C, (1987) Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med 13: 175–182 [CrossRef] [PubMed] [Google Scholar]
  • Picard C, Parrot A, Boussaud V, Lavole A, Saidi F, Mayaud C, Carette MF, (2003) Massive hemoptysis due to Rasmüssen aneurysm: detection with helicoidal CT angiography and successful steel coil embolization. Intensive Care Med 29: 1837–1839 [CrossRef] [PubMed] [Google Scholar]
  • Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS, (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307: 2526–2533 [PubMed] [Google Scholar]
  • Mailles A, Stahl JP, (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49: 1838–1847 [CrossRef] [PubMed] [Google Scholar]
  • Verdon R, Chevret S, Laissy JP, Wolff M, (1996) Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 22: 982–988 [CrossRef] [PubMed] [Google Scholar]
  • Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, (2009) British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59: 167–187 [CrossRef] [PubMed] [Google Scholar]
  • Raut T, Garg RK, Jain A, Verma R, Singh MK, Malhotra HS, Kohli N, Parihar A, (2013) Hydrocephalus in tuberculous meningitis: Incidence, its predictive factors and impact on the prognosis. J Infect 66: 330–337 [CrossRef] [PubMed] [Google Scholar]
  • Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, Seguin A, Bertheau P, Canet E, de Labarthe A, Darmon M, Rybojad M, Schlemmer B, Azoulay E, (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36: 1695–1702 [CrossRef] [PubMed] [Google Scholar]
  • Hagan G, Nathani N, (2013) Clinical review: tuberculosis on the intensive care unit. Crit Care 17: 240 [CrossRef] [PubMed] [Google Scholar]
  • World Heatlh Organization, (2010) Treatment of tuberculosis — Guidelines 4th Edition (available at www.who.int) [Google Scholar]
  • Anderson C, Inhaber N, Menzies D, (1995) Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 152: 1570–1574 [CrossRef] [PubMed] [Google Scholar]
  • Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL, (2017) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 64: 111–115 [CrossRef] [PubMed] [Google Scholar]
  • Cecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, Perez M, Poggi S, Ambroggi M, (2009) Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 13: 269–271 [PubMed] [Google Scholar]
  • Solomons RS, van Elsland SL, Visser DH, Hoek KG, Marais BJ, Schoeman JF, van Furth AM, (2014) Commercial nucleic acid amplification tests in tuberculous meningitis: a meta-analysis. Diagn Microbiol Infect Dis 78: 398–403 [Google Scholar]
  • Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JMJr, (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3: 633–643 [CrossRef] [PubMed] [Google Scholar]
  • Calligaro GL, Theron G, Khalfey H, Peter J, Meldau R, Matinyenya B, Davids M, Smith L, Pooran A, Lesosky M, Esmail A, Miller MG, Piercy J, Michell L, Dawson R, Raine RI, Joubert I, Dheda K, (2015) Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial. Lancet Respir Med 3: 621–630 [Google Scholar]
  • Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D, (2011) Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37: 88–99 [PubMed] [Google Scholar]
  • Diel R, Loddenkemper R, Nienhaus A, (2012) Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 142: 63–75 [PubMed] [Google Scholar]
  • Huo ZY, Peng L, (2016) Accuracy of the interferon-gamma release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis. BMC Infect Dis 16: 350 [CrossRef] [PubMed] [Google Scholar]
  • Haas CT, Roe JK, Pollara G, Mehta M, Noursadeghi M, (2016) Diagnostic 'omics' for active tuberculosis. BMC Med 14: 37 [CrossRef] [PubMed] [Google Scholar]
  • Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A, (2016) Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63: e147–195 [CrossRef] [PubMed] [Google Scholar]
  • Heemskerk AD, Bang ND, Mai NT, Chau TT, Phu NH, Loc PP, Chau NV, Hien TT, Dung NH, Lan NT, Lan NH, Lan NN, Phongle T, Vien NN, Hien NQ, Yen NT, Ha DT, Day JN, Caws M, Merson L, Thinh TT, Wolbers M, Thwaites GE, Farrar JJ, (2016) Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med 374: 124–134 [CrossRef] [PubMed] [Google Scholar]
  • Koegelenberg CF, Nortje A, Lalla U, Enslin A, Irusen EM, Rosenkranz B, Seifart HI, Bolliger CT, (2013) The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care. S Afr Med J 103: 394–398 [CrossRef] [PubMed] [Google Scholar]
  • Kim HS, Lee ES, Cho YJ, (2014) Insufficient serum levels of antituberculosis agents during venovenous extracorporeal membrane oxygenation therapy for acute respiratory distress syndrome in a patient with miliary tuberculosis. ASAIO J 60: 484–486 [CrossRef] [PubMed] [Google Scholar]
  • Singanayagam A, Sridhar S, Dhariwal J, Abdel-Aziz D, Munro K, Connell DW, George PM, Molyneaux PL, Cooke GS, Burroughs AK, Lalvani A, Wickremasinghe M, Kon OM, (2012) A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med 185: 653–659 [CrossRef] [PubMed] [Google Scholar]
  • Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, Sterling TR, (2006) An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 174: 935–952 [CrossRef] [PubMed] [Google Scholar]
  • Haute Autorité de santé, (2007) Tuberculose active (available at www.has-sante.fr) [Google Scholar]
  • Tiberi S, D'Ambrosio L, De Lorenzo S, Viggiani P, Centis R, Migliori GB, (2016) Tuberculosis elimination, patients’ lives and rational use of new drugs: revisited. Eur Respir J 47: 664–667 [PubMed] [Google Scholar]
  • Chang KC, Yew WW, Sotgiu G, (2015) Clinical research in the treatment of tuberculosis: current status and future prospects. Int J Tuberc Lung Dis 19: 1417–1427 [PubMed] [Google Scholar]
  • CNR-MyRMA, (2015) Résistance aux antituberculeux en France en 2013. Bull Epidemiol Hebd 9–10: 172–174 [Google Scholar]
  • Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Farrar JJ, (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351: 1741–1751 [CrossRef] [PubMed] [Google Scholar]
  • Prasad K, Singh MB, Ryan H, (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 4: CD002244 [PubMed] [Google Scholar]
  • Critchley JA, Young F, Orton L, Garner P, (2013) Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 13: 223–237 [CrossRef] [PubMed] [Google Scholar]
  • Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Chitsa Banda A, Brown B, Manga P, Kirenga B, Mondo C, Mntla P, Tsitsi JM, Peters F, Essop MR, Russell JB, Hakim J, Matenga J, Barasa AF, Sani MU, Olunuga T, Ogah O, Ansa V, Aje A, Danbauchi S, Ojji D, Yusuf S, (2014) Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med 371: 1121–1130 [CrossRef] [PubMed] [Google Scholar]
  • Engel ME, Matchaba PT, Volmink J, (2007) Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev: CD001876 [PubMed] [Google Scholar]
  • World Heatlh Organization — Reginal Office for Europe, (2014) The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB (available at www.euro.who.int) [Google Scholar]
  • Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, Menzies D, (2016) Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: an individual patient data meta-analysis. Clin Infect Dis 62: 887–895 [CrossRef] [PubMed] [Google Scholar]
  • Rajshekhar V, (2015) Surgery for brain tuberculosis: a review. Acta Neurochir (Wien) 157: 1665–1678 [CrossRef] [PubMed] [Google Scholar]
  • Bloch S, Wickremasinghe M, Wright A, Rice A, Thompson M, Kon OM, (2009) Paradoxical reactions in non–HIV tuberculosis presenting as endobronchial obstruction. Eur Respir Rev 18: 295–299 [CrossRef] [PubMed] [Google Scholar]
  • Hawkey CR, Yap T, Pereira J, Moore DA, Davidson RN, Pasvol G, Kon OM, Wall RA, Wilkinson RJ, (2005) Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 40: 1368–1371 [CrossRef] [PubMed] [Google Scholar]
  • Nicolls DJ, King M, Holland D, Bala J, del Rio C, (2005) Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 5: 795–801 [CrossRef] [PubMed] [Google Scholar]
  • Cheng SL, Wang HC, Yang PC, (2007) Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 11: 1290–1295 [PubMed] [Google Scholar]
  • Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, Cheung WC, Yuen KY, (2003) Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 22: 597–602 [PubMed] [Google Scholar]
  • Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, Molina JM, Schlemmer B, Azoulay E, (2010) Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 14: R107 [CrossRef] [PubMed] [Google Scholar]
  • Institut de veille sanitaire, (2015) Infection par le VIH/sida et les IST. Point épidémiologique du 23 novembre 2015 (available at http://invs.santepubliquefrance.fr/fr) [Google Scholar]
  • Barbier F, Roux A, Canet E, Martel-Samb P, Aegerter P, Wolff M, Guidet B, Azoulay E, (2014) Temporal trends in critical events complicating HIV infection: 1999–2010 multicentre cohort study in France. Intensive Care Med 40:1906–15 [CrossRef] [PubMed] [Google Scholar]
  • Abdool-Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q, (2011) Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 365: 1492–1501 [CrossRef] [PubMed] [Google Scholar]
  • Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q, (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362: 697–706 [CrossRef] [PubMed] [Google Scholar]
  • Uthman OA, Okwundu C, Gbenga K, Volmink J, Dowdy D, Zumla A, Nachega JB, (2015) Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis. Ann Intern Med 163: 32–39 [CrossRef] [PubMed] [Google Scholar]
  • Groupe d'experts ANS-CNRS. Prise en charge médicale des personnes vivant avec le VIH : rapport 2013 (available at www.sante.gouv.fr) [Google Scholar]
  • Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10: 251–261 [CrossRef] [PubMed] [Google Scholar]
  • Poulakou G, Bassetti M, Timsit JF, (2016) Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe. Intensive Care Med 42: 245–248 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.